InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Greene Barry E, 董事长兼首席执行官. Director active across 2 companies, notably Sage Therapeutics, Inc.. Cumulatively, 7 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €1.8m. Activity tracked since 16 June 2021. The latest transaction was filed on 10 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Greene Barry E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
46,940 股Common StockSEC:0000950170-25-100636:0
19,964 股0Common StockSEC:0001562180-25-003112:0
50,400 股0Common StockSEC:0001562180-24-006090:0
14,500 股@ US$34.484316.4% 占其流量Common StockSEC:0001562180-22-007667:0
标准退出：2023年2月8日 (T+90)
7,576 股@ US$1.485100.0% 占其流量Common StockSEC:0001209191-22-045718:0
23,640 股@ US$43.149548.6% 占其流量Common StockSEC:0001562180-21-005226:0
标准退出：2021年11月3日 (T+90)
8,800 股@ US$56.321323.3% 占其流量Common StockSEC:0001562180-21-004342:0
标准退出：2021年9月14日 (T+90)
7 条申报中的 7 条
About Greene Barry E
Barry E. Greene is the President and CEO of Sage Therapeutics, Inc. He leads the company with a focus on innovation in healthcare. Under his leadership, Sage Therapeutics is committed to developing innovative treatments for patients.
